These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10437128)

  • 1. Kanglemycin C vs ciclosporin on immunosuppression in mice.
    Li JM; Lin ZB
    Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):65-8. PubMed ID: 10437128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effect of kanglemycin C on T- and B-lymphocyte activation.
    Li JM; Lin ZB
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):546-50. PubMed ID: 10678151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of kanglemycin C on lymphocyte proliferation induced by tetradecanoylphorbol acetate and ionomycin.
    Li JM; Lin ZB
    Acta Pharmacol Sin; 2000 Feb; 21(2):188-92. PubMed ID: 11263270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
    Shi W; Xie L; Wang S
    Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of skin allograft survival by combined feeding of donor spleen cells and cyclosporine in mice.
    Lu X; Zhou L; Chen S
    Transplant Proc; 2004 Oct; 36(8):2429-31. PubMed ID: 15561269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cyclosporin and portal venous inoculation of donor splenocytes prolongs cardiac allograft survival in mice].
    Zhou HK; Yu LX; Zheng SB; Min ZL; Zhu YH
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1093-5. PubMed ID: 12480604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of MD-1 expression by immunosuppressants or antisense oligodeoxynucleotides on skin allograft survival in mice.
    Zhang X; Chen BC; Xiang FL; Chang S; Zhou HM; Du DF; Yuan J; Chen ZK
    Transplant Proc; 2005 May; 37(4):1965-7. PubMed ID: 15919519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacological profiles of cyclosporine, (Nva2)-cyclosporine and (Val2)dihydro-cyclosporine.
    Hiestand PC; Gunn HC; Gale JM; Ryffel B; Borel JF
    Immunology; 1985 Jun; 55(2):249-55. PubMed ID: 3891595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J; Liu J; Xie S
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study on induction of skin allograft tolerance in mice by heat shock protein 60].
    Huang W; Ye Q; Huang Z; Yang D; Peng M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Aug; 22(8):993-7. PubMed ID: 18773821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of berberine on DNFB-induced delayed type hypersensitivity in mice].
    Du LR; He XH; Xu LH; Zeng YY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):418-21. PubMed ID: 15989781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of skin graft survival rates in BALB/c mice treated with either cyclosporine A, cyclosporine G, or 1/1 combination of both.
    Masri MA
    Transplant Proc; 1992 Oct; 24(5):1661-2. PubMed ID: 1412788
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
    Arita S; Kasraie A; Une S; Ohtsuka S; Smith CV; Mullen Y
    Cell Transplant; 2001; 10(7):639-44. PubMed ID: 11714199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new cyclosporine derivative, SDZ IMM 125: in vitro and in vivo pharmacologic effects.
    Hiestand PC; Gräber M; Hurtenbach U; Herrmann P; Cammisuli S; Richardson BP; Eberle MK; Borel JF
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):31-8. PubMed ID: 1386701
    [No Abstract]   [Full Text] [Related]  

  • 17. Operational tolerance in nonvascularized transplant models induced by AR-C117977, a monocarboxylate transporter inhibitor.
    Påhlman C; Malm H; Qi Z; Veress B; Ferguson D; Bundick R; Murray C; Donald D; Ekberg H
    Transplantation; 2008 Oct; 86(8):1135-8. PubMed ID: 18946353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. J2 prolongs the corneal allograft survival through inhibition of the CD4+ T cell-mediated response in vivo.
    Xiao H; Zhang H; Yu ZY; Zhang L; Yu M; Huang YF; Li S; Shen BF; Li Y
    Transpl Immunol; 2007 Nov; 18(2):130-7. PubMed ID: 18005857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720 inhibits TH1-mediated allogeneic humoral immune response.
    Peñuelas-Rivas G; Domínguez-Perles R; Brinkmann V; Del Rio ML; Muñoz-Luna A; Ramírez-Romero P; Parrilla-Paricio P; Rodríguez-Barbosa JI
    Transplant Proc; 2005 Nov; 37(9):4124-6. PubMed ID: 16386642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suppressive effects of adenosine on nonspecific and humoral immunities in mice].
    Feng YX; Liu F; Bian D; Hu J
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):473-6. PubMed ID: 7717080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.